28-Mar-2024
No headlines found.
Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
Globe Newswire (Thu, 14-Mar 7:00 AM ET)
Globe Newswire (Tue, 12-Mar 7:00 AM ET)
Autolus Therapeutics announces publication in Blood Cancer Journal
Globe Newswire (Mon, 11-Mar 7:00 AM ET)
Globe Newswire (Thu, 29-Feb 7:00 AM ET)
Autolus Therapeutics announces publication in Nature Communications
Globe Newswire (Thu, 22-Feb 7:00 AM ET)
Autolus Announces Pricing of Underwritten Offering
Globe Newswire (Thu, 8-Feb 7:00 AM ET)
Globe Newswire (Thu, 8-Feb 5:45 AM ET)
Autolus Therapeutics announces publication in ACS Chemical Biology
Globe Newswire (Tue, 23-Jan 7:00 AM ET)
Globe Newswire (Mon, 22-Jan 7:00 AM ET)
Autolus Therapeutics announces the appointment of Robert W. Azelby to its Board of Directors
Globe Newswire (Wed, 10-Jan 7:00 AM ET)
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
Autolus Therapeutics PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol AUTL.
As of March 28, 2024, AUTL stock price climbed to $6.38 with 646,994 million shares trading.
AUTL has a beta of 2.84, meaning it tends to be more sensitive to market movements. AUTL has a correlation of 0.15 to the broad based SPY ETF.
AUTL has a market cap of $1.70 billion. This is considered a Small Cap stock.
In the last 3 years, AUTL stock traded as high as $8.23 and as low as $1.60.
The top ETF exchange traded funds that AUTL belongs to (by Net Assets): IBB, CNCR, INNO, GWX, BIB.
AUTL has outperformed the market in the last year with a price return of +244.9% while the SPY ETF gained +33.6%. However, in the short term, AUTL had mixed performance relative to the market. It has underperformed in the last 3 months, returning -3.8% vs +10.1% return in SPY. But in the last 2 weeks, AUTL shares have fared better than the market returning +16.4% compared to SPY +1.7%.
AUTL support price is $5.97 and resistance is $6.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AUTL stock will trade within this expected range on the day.